Myocardial 'low reflow' assessed by Dy-DTPA-BMA-enhanced first-pass MR imaging in a dog model

Journal of Magnetic Resonance Imaging

Volumn 9, Issue 5, 1999, Pages 679-684

  Arteaga, C ^a   Revel, D ^a   Zhao, S ^a   Hadour, G ^b   Forrat, R ^b   Oksendal, A ^c   Canet, E ^a  

^a UNIVERSITÉ DE LYON   (France)

^b INSERM   (France)

^c NYCOMED IMAGING AS   (Norway)

Author keywords

Contrast media; Magnetic resonance imaging; Myocardial infarction; Perfusion imaging

Indexed keywords

CONTRAST MEDIUM; DYSPROSIUM PENTETATE BIS(METHYLAMIDE); SPRODIAMIDE; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ANIMAL MODEL; ARTICLE; BOLUS INJECTION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOG; HEART MUSCLE PERFUSION; HEMODYNAMIC PARAMETERS; IMAGE ANALYSIS; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 0032900902     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1522-2586(199905)9:5<679::AID-JMRI9>3.0.CO;2-K     Document Type: Article

References (18)

1. Saeed M, Wendland MF, Higgins CB. Contrast media for MR imaging of the heart. J Magn Reson Imaging 1994;4:269-279.
2. Masui T, Saeed M, Wendland MF. Higgins CB. Occlusive and reperfused myocardial infarcts: MR imaging differentiation with nonionic Gd-DTPA-BMA. Radiology 1991;181:77-83.
3. Saeed M, Wendland MF, Masui T, Higgins CB. Reperfused myocardial infarctions on T1- and susceptibility-enhanced MRI: evidence for loss of compartmentalization of contrast media. Magn Reson Med 1994;31:31-39.
4. Saeed M, Wendland MF, Higgins CB. Characterization of reperfused myocardial infarctions with T1 -enhancing and magnetic susceptibility-enhancing contrast media. Invest Radiol 1991;26:3239-5241.
5. Geschwind JF, Wendland MF, Saeed M, Lauerma L, Derugin N, Higgins CB. Identification of myocardial cell death in reperfused myocardial injury using dual mechanisms of contrast-enhanced magnetic resonance imaging. Acad Radiol 1994;1:319-325.
6. Saeed M, Wendland MF, Yu KK, et al. Identification of myocardial reperfusion with echo-planar magnetic resonance imaging. Discrimination between occlusive and reperfused infarctions. Circulation 1994;90:1492-1501.
7. Ovize M, Revel D, De Lorgeril M, et al. Quantification of reperfused myocardial infarction by Gd-DOTA enhanced magnetic resonance imaging. Invest Radiol 1991;26:1065-1070.
8. Kloner RA, Ganote CE, Jennings RG. The no reflow phenomenon after temporary coronary occlusion in dogs. J Clin Invest 1974;54: 1496-1508.
9. Canet E, Revel D, Sebbag L, et al. Noninvasive assessment of no-reflow phenomenon in a canine model of reperfused infarction by contrast-enhanced magnetic resonance imaging. Am Heart J 1995;130:949-959.
10. Judd RM, Lugo-Olivieri CH, Arai M, et al. Phsyiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canin infarcts. Circulation 1995;92: 1902-1910.
11. Ito H, Maruyama A, Iwakura K, et al. Clinical implications of the 'no-reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996;93:223-228.
12. Saeed M, Wendland MF, Tomei E, et al. Demarcation of myocardial ischemia: magnetic susceptibility effect of contrast medium in MR imaging. Radiology 1989;173:763-767.
13. Kyle K, Saeed M, Wendland MF, et al. Comparison of T1-enhancing and magnetic susceptibility magnetic resonance contrast agents for demarcation of the jeopardy area in experimental myocardial infarction. Invest Radiol 1993;28:1015-1023.
14. Haraldseth O, Jones RA, Muller TB, Fahlvik AK, Oksendal AN. Comparison of dysprosium DTPA BMA and superparamagnetic iron oxide particles as susceptibility contrast agents for perfusion imaging of regional cerebral ischemia in the rat. J Magn Reson Imaging 1996;6:714-717.
15. Ostergaard L, Sorensen A, Kwong K, Weisskoff R, Gyldensted C, Rosen B. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: Experimental comparison and preliminary results. Magn Reson Med 1996;36:726-736.
16. Sakuma H, O'Sullivan M, Lucas J, et al. Effect of magnetic susceptibility contrast medium on myocardial intensity with fast gradient-recalled echo and spin-echo MR imaging: initial experience in humans. Radiology 1994;190:161-166.
17. Donahue K, Weisskoff R, Burstein D. Water diffusion and exchange as they influence contrast enhancement. J Magn Reson Imaging 1997;7:102-110.
18. Fossheim S, Saebo K, Fahlvik A, Rongved P, Klaveness J. Low molecular weight lanthanide contrast agents: in vitro studies of mechanisms of action. J Magn Reson Imaging 1997;:251-257.